People in the U.S. who used any GoodRx website, app or service, including GoodRx Gold, HeyDoctor and GoodRx Care, before April 20, 2024 may qualify to claim an equal share of the $32 million GoodRx privacy class action settlement. Claims are open on the official settlement website with no receipts, documents or notice ID required, and claims close December 29, 2026.
Current Status
Claims are open in the $32 million settlement between GoodRx, the ad-technology company Criteo and people who used GoodRx before April 20, 2024. The official settlement website, goodrxprivacysettlement.com, was live and accepting online claims as of October 23, 2026, and the online claim form asks for no receipts, documents or notice ID. The deadline is December 29, 2026: online claims are due by 11:59 p.m. Eastern Time that day, and mailed claim forms must be postmarked by that date. The court granted preliminary approval on September 8, 2026, and the final approval hearing is set for February 11, 2027. No payment date had been announced as of October 23, 2026.Free settlement alerts
Get notified when new class actions open to claims
Join thousands of readers who get the latest class action settlements you may qualify for — delivered straight to your inbox.
What Changed Recently?
On September 8, 2026, U.S. District Judge Araceli Martínez-Olguín of the Northern District of California preliminarily approved the settlement in Doe, et al. v. GoodRx Holdings, Inc., et al., No. 4:23-cv-00501-AMO. The order provisionally certified a nationwide settlement class, appointed A.B. Data as the settlement administrator, approved the notice plan and set every deadline that now applies. The settlement website appeared online in mid-October with a File a Claim page, but the claims administrator said it had been switched on only to complete testing, and claims submitted during that phase were rejected as untimely. The site returned a hosting error on October 18 and a maintenance page on October 21, 2026. By October 23, 2026, it was back online and accepting claims, with the December 29, 2026 deadline unchanged. Anyone who filed during the testing phase has to file again. The earlier outage is covered in GoodRx settlement website: claims now open.The case centers on allegations that GoodRx passed users’ health and prescription information to advertising companies through tracking code on its website and app. GoodRx and Criteo deny the allegations and deny violating any law; they agreed to settle to avoid the cost and uncertainty of further litigation, and the settlement is not a finding of wrongdoing. When the deal was first filed in June 2026, before the court had acted on it, the claim window had not opened and no deadlines had been set; OCA’s earlier report on that stage is GoodRx agrees to $32 million privacy settlement.
Who Qualifies?
The settlement class is all natural persons in the United States who used any website, app or service made available by or through GoodRx at any time before April 20, 2024. That reaches the main GoodRx website and app as well as GoodRx Gold, HeyDoctor and GoodRx Care. The class is not limited to people who received an email notice, and it is not limited by state.Excluded from the class are GoodRx and Criteo and their affiliates, parents, subsidiaries, officers and directors; Meta and Google; anyone who opts out; and the judges presiding over the case and their clerks.
Meta Platforms and Google are defendants in the same lawsuit, but they are not part of this settlement. The plaintiffs’ claims against those two companies continue separately, so this deal pays only for the claims against GoodRx and Criteo.
How Much Can You Get?
GoodRx and Criteo agreed to pay $32,000,000 into a non-reversionary settlement fund, meaning no leftover money goes back to either company. Before anything is divided among claimants, the fund pays notice and administration costs, taxes, fund account costs, any attorneys’ fees and expenses the court awards, service awards for the class representatives, and any other costs the court approves. What remains is the net settlement fund.Every class member who files a valid, timely claim receives the same amount: the net fund divided by the number of valid claims. Neither the notice nor the settlement website gives a per-person estimate, because the figure depends entirely on how many people file. Class Counsel, Lowey Dannenberg, P.C. and Bursor & Fisher, P.A., have said they will ask for attorneys’ fees of no more than one-third of the fund (about $10.67 million) plus up to $125,000 in litigation expenses, and the class representatives may request service awards of up to $2,000 each. The court decides those requests at or after the final approval hearing.
Claimants choose how to be paid on the claim form: PayPal, Venmo, Zelle, a virtual prepaid card or a physical check mailed to the address on the form. If the electronic payment details are not enough to send the money, the administrator mails a check instead. Checks become void if they are not cashed within 60 days of issue.
What Proof or Notice ID Is Required?
No proof is required. The live online claim form, reviewed on the settlement website on October 23, 2026, asks for the claimant’s first and last name, a street address, city, state, ZIP code, email address and phone number, a payment choice, and an electronic signature. It has no place to upload receipts or other documents. It does include an optional field for a Unique ID and PIN from the notice, and the form states that this is not required to file a claim; class members who have one can enter it to help the administrator process the claim. The claim form page’s web address is labeled for class members who did not receive a notice.What the form does require is an attestation: the claimant checks a box stating that they resided in the United States and used a website, app or service made available by or through GoodRx before April 20, 2024, and certifies that the information on the form is true, correct and complete. Filing is open to class members only. The administrator reviews each claim for validity, timeliness and completeness and has the right to audit claims for fraud; a claimant whose form is found incomplete gets written notice and 20 days to fix it, or the claim is treated as invalid.
What Is the Deadline?
Claims are due December 29, 2026. An online claim must be submitted by 11:59 p.m. Eastern Time that day; a paper claim form must be postmarked no later than December 29, 2026.The same date applies to the two other options a class member has. A request to be excluded from the settlement must be mailed and postmarked by December 29, 2026; it cannot be made by phone or email, and it has to include the case name and number, the person’s full name, address, phone number and email, the claimant ID code and other information from the summary notice, an original signature, and a clear statement of intent to be excluded. Someone who opts out receives no payment and keeps the right to pursue their own claims against GoodRx and Criteo. A written objection must be filed with the court by December 29, 2026, and only class members who stay in the settlement may object.
How Do You Take Action?
Claims are filed on the GoodRx Privacy Settlement online claim form, the page behind the File a Claim button on the official settlement website. Online claims are due by 11:59 p.m. Eastern Time on December 29, 2026. Claims filed while the site was in testing were rejected and have to be filed again. A claim on any other address, including the staging server goodrxprivacysettlement-web-staging.azurewebsites.net, is not a claim in this settlement.The online form takes contact details, a payment method, the attestation checkbox and a typed signature. A printable claim form is also posted on the settlement website for anyone who prefers to mail one, postmarked by December 29, 2026, and it lists the administrator’s mailing address. The claim form, notice and court orders are collected on the site’s court documents page. A section-by-section look at the online form, including its five payment options and the optional Unique ID and PIN box, is in GoodRx settlement claim form is live: what it asks for.
Questions about a specific claim go to A.B. Data through the contact options listed on the settlement website. The notice asks class members not to contact the court or the clerk’s office about the settlement.
What Happens Next?
Class Counsel’s motions for final approval, attorneys’ fees and expenses, and service awards are due November 24, 2026, and the notice says they will be posted on the settlement website once filed. After the December 29 deadlines pass, the court’s schedule gives the parties until January 28, 2027 to complete discovery about any objections and until February 2, 2027 to respond to them.The final approval hearing is scheduled for February 11, 2027, at 11:00 a.m. before Judge Martínez-Olguín in Courtroom 5 of the federal courthouse in Oakland. The notice warns that the date or time may change without further notice and that the hearing could be held remotely. Final approval is not guaranteed, and any approval can be appealed.
Under the settlement agreement, the administrator sends payments within 45 days after the Effective Date, which comes only after final approval and the end of any appeals. The notice cautions that an appeal can take a year or more to resolve. No payment date had been announced as of October 23, 2026.
What the Lawsuit Alleges
GoodRx runs a prescription-coupon and telehealth business. The plaintiffs allege that from at least 2017 to 2020, GoodRx disclosed users’ personal and health information, including information about their prescriptions and health conditions, email addresses and phone numbers, to advertising and analytics companies, among them Criteo, Meta and Google. According to the complaint, the data moved through JavaScript pixels, software development kits, cookies and APIs built into GoodRx’s website and apps, and the receiving companies then used the information for their own purposes.The plaintiffs assert claims for intrusion upon seclusion, unjust enrichment, negligence and negligence per se, along with alleged violations of the California Confidentiality of Medical Information Act, the California Invasion of Privacy Act, the California Consumers Legal Remedies Act, California’s Unfair Competition Law, New York’s General Business Law and the Illinois Consumer Fraud and Deceptive Business Practices Act. GoodRx and Criteo dispute the allegations, deny violating any law and maintain that they have meritorious defenses. The court has not ruled for either side on the merits.
The private suits followed a Federal Trade Commission action filed against GoodRx on February 1, 2023, in which the FTC alleged that GoodRx violated the FTC Act and the agency’s Health Breach Notification Rule by disclosing users’ personal information and medication and health-condition details to third parties. GoodRx resolved that case without a trial: under a stipulated order the court entered on February 17, 2023, it paid a $1.5 million civil penalty and agreed to a ban on sharing users’ health information for advertising, according to the Justice Department. That penalty went to the government, not to consumers, and it is separate from this $32 million class settlement. The first class complaints were filed on February 2, 2023, the day after the FTC action, and were consolidated into this case in May 2023. GoodRx reached a settlement with the plaintiffs after mediation in 2024; the court denied without prejudice the motion to approve that GoodRx-only deal on June 12, 2025. Criteo followed in 2025, and the combined amended agreement was signed November 19, 2025. A March 24, 2026 addendum narrowed the release so that it covers claims tied to the alleged data disclosure through tracking technologies on GoodRx’s website, app and related services before April 20, 2024, or claims based on the complaint’s factual allegations.
Class members who stay in the settlement give up the right to sue GoodRx, Criteo and their related parties over those released claims, whether or not they file a claim. The release does not reach Meta or Google.
Sources and Verification
This page is based on the court-approved documents, the settlement website and the claims administrator:- The official GoodRx Privacy Settlement website, including its FAQ and the live online claim form, reviewed October 23, 2026, when it was open for claims. The site had been in testing when first reviewed on October 14, 2026, returned “Error 403 – This web app is stopped” on October 18, 2026 and showed a maintenance page on October 21, 2026.
- The claims administrator’s email reply to a class member, subject “Re: Error 403 on claim,” reviewed October 21, 2026, which says the site was activated for testing, claim filing begins when notices issue (anticipated the week of October 19, 2026), and claims submitted during testing were rejected.
- The long-form Notice of Proposed Class Action Settlement, embedded below.
- The court docket for this class action, Doe v. GoodRx Holdings, Inc., No. 4:23-cv-00501 (N.D. Cal.), on CourtListener, including the plaintiffs’ unopposed motion for preliminary approval (ECF No. 357, filed June 1, 2026), which names A.B. Data, Ltd. as the proposed settlement administrator, and the September 3, 2026 hearing and September 8, 2026 order entries.
- The docket for the government’s separate case, United States v. GoodRx Holdings, Inc., No. 4:23-cv-00460 (N.D. Cal.), and the Justice Department’s February 22, 2023 announcement of the $1.5 million civil penalty.
- The Order Preliminarily Approving the Proposed Class Action Settlement (ECF No. 379, entered September 8, 2026), the Amended Class Action Settlement Agreement and Release dated November 19, 2025, the March 24, 2026 addendum, the summary notice and the claim form, all posted on the settlement website’s court documents page.
OpenClassActions.com is a consumer news and information site, not a law firm. This article is general information about the GoodRx privacy settlement. It is not legal advice, and reading it does not create an attorney-client relationship.
Questions
Is the GoodRx settlement claim form open?
The claim form is open. As of October 23, 2026, the official settlement website, www.goodrxprivacysettlement.com, was live and accepting claims through its File a Claim page. Online claims are due by 11:59 p.m. Eastern Time on December 29, 2026, and mailed claim forms must be postmarked by that date. The website had been switched on earlier in October only for testing, before claim filing officially began.
Does a GoodRx claim filed during the testing phase count?
According to the claims administrator, any claim submitted while the website was in testing was not timely and was rejected, and those claimants have to submit a new claim. Claim filing is now open, and a new claim is timely if it is submitted by the December 29, 2026 deadline.
Is goodrxprivacysettlement-web-staging.azurewebsites.net the official GoodRx settlement site?
No. That address is a staging, or test, server. The only settlement website named in the court’s preliminary approval order is www.goodrxprivacysettlement.com.
Does the GoodRx settlement cover Meta and Google?
The $32 million settlement resolves the claims against GoodRx Holdings, Inc. and Criteo Corp. only. Meta and Google are also defendants in the same case, but the plaintiffs’ claims against them are not part of this deal and are still being litigated. Meta and Google are also excluded from the settlement class, and the release covers GoodRx, Criteo and their related parties.
Is the Unique ID and PIN from the GoodRx notice required to file a claim?
The online claim form has an optional field for a Unique ID and PIN from the notice, and the form states that it is not required to file a claim; entering it only helps the administrator process the claim. The form asks for name, street address, email, phone number, a payment choice, an attestation about U.S. residence and GoodRx use before April 20, 2024, and an electronic signature, with no receipts or documents to upload. The Claimant ID code does matter for a different step: a written request to be excluded from the settlement has to include it.
Can one person file more than one GoodRx claim?
The claim form limits each settlement class member to one claim for one pro rata cash payment, regardless of how many notices that person receives. Someone completing the form on behalf of another person has to attach documentation showing their authority to act for that claimant.
How is the GoodRx class action related to the FTC case?
According to the settlement notice, the Federal Trade Commission filed an action against GoodRx on February 1, 2023, alleging that it violated the FTC Act and the FTC’s Health Breach Notification Rule by disclosing users’ personal information and details about their medications and health conditions to third parties. Private class actions began the next day and were consolidated in May 2023. The FTC matter is a separate government action; this $32 million settlement resolves only the private class claims against GoodRx and Criteo.
What happens to GoodRx settlement money that is not cashed?
Settlement checks become void if they are not cashed within 60 days of issue. Under the settlement agreement, money left over from uncashed checks is redistributed pro rata to claimants who cashed their checks or chose an electronic payment, as long as each redistributed share would be at least $5. Any money still left more than 180 days after payments go out goes to the Center for Internet and Society at Stanford Law School. None of it returns to GoodRx or Criteo.
Did the court reject an earlier GoodRx settlement?
An earlier version was turned down. On June 12, 2025, the court denied without prejudice the first motion to approve a settlement with GoodRx alone, according to the court docket. The parties then brought Criteo into the deal, signed an amended $32 million agreement on November 19, 2025, narrowed the release in a March 24, 2026 addendum and filed a new motion on June 1, 2026. The court granted preliminary approval of that amended settlement on September 8, 2026, which is the settlement now open for claims.
Could the GoodRx settlement still fall apart?
Final approval is not guaranteed. The court has granted only preliminary approval, and final approval will be considered at the February 11, 2027 hearing. Separately, GoodRx and Criteo have the right, but not the obligation, to terminate the settlement if the number of class members who opt out exceeds a threshold set in a confidential side agreement. If the settlement is not approved or is terminated, no settlement payments are made and the case continues against GoodRx and Criteo.
